We have a growing mental health crisis and available treatments are limited. There are 12 million U.S. Citizens with PTSD, 20 million with depression, and close to 20 million with substance use disorder. Psychedelic-assisted therapy offers the most effective mental health treatment ever studied. In MAPS Phase III Clinical trials (MDMA-therapy for PTSD), 67% of trial participants treated with MDMA no longer qualified as having a PTSD diagnosis after suffering for 14 years on average after just three treatments with MDMA. Similar results are being shown using psilocybin-assisted therapy for depression. We invest in cutting edge research into these compounds, advocacy efforts, education and delivery of care. Below are a list of the organizations we support.